Mastering contraception means empowering patients to control their reproductive futures with precision and confidence. You'll explore the mechanisms behind hormonal methods that hijack the endocrine axis, barriers that block sperm at the gate, intrauterine devices that transform the uterine environment, emergency protocols that prevent implantation, and permanent sterilization techniques that end fertility decisively. Understanding each method's efficacy, contraindications, and patient-specific considerations transforms you from prescriber to trusted counselor, matching individuals to the contraceptive strategy that fits their bodies, lives, and goals.
📌 Remember: COILS for contraceptive categories - Combined hormonal, Oral progestin-only, Intrauterine devices, Long-acting reversible, Sterilization methods
Modern contraception achieves >99% efficacy with perfect use across multiple categories. Combined oral contraceptives (COCs) demonstrate 91% typical-use effectiveness, while intrauterine devices maintain >99.2% efficacy regardless of user compliance. Long-acting reversible contraceptives (LARCs) show superior real-world performance due to elimination of daily adherence requirements.
| Method Category | Perfect Use Efficacy | Typical Use Efficacy | Duration | Reversibility | Cost per Year |
|---|---|---|---|---|---|
| Combined Pills | 99.7% | 91% | Daily | Immediate | $240-600 |
| Progestin Pills | 99.5% | 91% | Daily | Immediate | $180-480 |
| Copper IUD | 99.2% | 99.2% | 10 years | 12 months | $50-80 |
| Hormonal IUD | 99.8% | 99.8% | 3-7 years | 12 months | $60-120 |
| Implant | 99.95% | 99.95% | 3 years | 3 months | $150-200 |
⭐ Clinical Pearl: Patients with BMI >30 show decreased efficacy with emergency contraception pills (40% reduction) and potential reduced effectiveness with transdermal patches due to altered pharmacokinetics
💡 Master This: Contraceptive selection requires systematic evaluation of medical history, lifestyle factors, and reproductive goals-master the contraindication matrix, and you predict every adverse outcome before it occurs
The contraceptive landscape includes 15+ distinct methods with varying mechanisms, efficacy profiles, and clinical considerations. Hormonal methods affect multiple organ systems through estrogen and progestin pathways, while non-hormonal options provide alternatives for patients with hormonal contraindications or preferences.
Connect foundational contraceptive knowledge through hormonal mechanisms to understand how estrogen and progestin create multilayered pregnancy prevention.
📌 Remember: STOP for hormonal contraceptive mechanisms - Suppression of ovulation, Thickening of cervical mucus, Ovarian follicle disruption, Prevention of endometrial receptivity
Combined oral contraceptives contain ethinyl estradiol (15-35 mcg) plus synthetic progestins in 21-day active cycles. Monophasic formulations maintain constant hormone levels, while triphasic preparations vary progestin doses to mimic natural cycles. Extended-cycle regimens reduce menstrual frequency from 13 to 4 cycles annually.
| Progestin Type | Androgenic Activity | Estrogenic Activity | VTE Risk | Acne Effect | Weight Impact |
|---|---|---|---|---|---|
| Levonorgestrel | High | Low | Baseline | Worsens | +1-2 kg |
| Norgestimate | Low | Moderate | Low | Improves | Neutral |
| Desogestrel | Low | High | Increased | Improves | +0.5-1 kg |
| Drospirenone | Anti-androgenic | Low | Highest | Improves | -0.5 kg |
| Cyproterone | Anti-androgenic | Low | High | Improves | +1 kg |
⭐ Clinical Pearl: Drospirenone-containing COCs increase VTE risk by 6-fold compared to levonorgestrel formulations (6-12 per 10,000 woman-years vs 2 per 10,000), requiring careful thrombosis risk assessment

Long-acting hormonal methods provide superior typical-use efficacy through elimination of daily compliance requirements. Depot medroxyprogesterone acetate (DMPA) delivers 150mg intramuscularly every 12 weeks, achieving >99% efficacy with delayed return to fertility averaging 12-18 months post-discontinuation.
💡 Master This: Hormonal contraceptive selection depends on balancing efficacy, side effect profiles, and individual risk factors-understand progestin pharmacology, and you predict every metabolic and vascular outcome
Contraceptive implants release continuous progestin for 3-5 years, maintaining therapeutic levels through zero-order kinetics. Etonogestrel implants suppress ovulation in >95% of cycles during first two years, with gradual decline to 85% by year three while maintaining >99% pregnancy prevention.
Connect hormonal mechanisms through barrier methods to understand how physical contraceptives provide hormone-free pregnancy prevention with distinct efficacy profiles.
Condom effectiveness depends critically on correct application timing, appropriate sizing, and compatible lubricant selection. Latex condoms provide >99% protection against HIV transmission and >95% protection against bacterial STIs, while polyurethane alternatives accommodate latex allergies affecting 1-6% of population.
📌 Remember: SHIELD for barrier method types - Spermicides, Hormone-free options, Internal (female) condoms, External (male) condoms, Latex and non-latex, Diaphragms and caps
| Barrier Method | Typical Use Efficacy | Perfect Use Efficacy | STI Protection | Duration | User Requirements |
|---|---|---|---|---|---|
| Male Condom | 85% | 98% | Excellent | Single use | Proper application |
| Female Condom | 79% | 95% | Excellent | Single use | Insertion technique |
| Diaphragm + Spermicide | 88% | 94% | None | 6 hours | Fitting, placement |
| Cervical Cap | 84% | 91% | None | 48 hours | Professional fitting |
| Contraceptive Sponge | 76-88% | 89-91% | None | 24 hours | Insertion depth |
⭐ Clinical Pearl: Nonoxynol-9 spermicide used >2 times daily increases HIV transmission risk by disrupting vaginal epithelium-recommend condom-only protection for high-risk patients
Spermicides contain nonoxynol-9 (2-4%) or benzalkonium chloride, creating hostile vaginal environment through sperm membrane disruption. Standalone spermicide efficacy reaches only 72% typical use, requiring combination with barrier methods for optimal pregnancy prevention.

Female condoms provide dual protection against pregnancy and STIs while offering female-controlled contraception. Polyurethane construction allows oil-based lubricant compatibility and heat transfer for enhanced sensation compared to latex male condoms.
💡 Master This: Barrier method success requires proper education, consistent use, and appropriate method selection based on individual anatomy and preferences-master fitting techniques and user education, and you maximize real-world effectiveness
Contraceptive sponges combine barrier and spermicidal mechanisms through polyurethane foam containing 1000mg nonoxynol-9. Pre-moistened design eliminates preparation requirements, while 24-hour protection allows multiple acts without additional applications.
Connect barrier methods through intrauterine devices to understand how long-acting reversible contraceptives provide superior efficacy through continuous uterine presence.
Copper T380A devices release copper ions at 50-80 mcg daily, creating spermicidal environment and preventing fertilization in >99% of cycles. Inflammatory response generates copper-containing macrophages and increased prostaglandins, making uterine environment hostile to sperm survival and embryo implantation.
📌 Remember: GUARD for IUD mechanisms - Gamete transport disruption, Uterine environment modification, Anti-fertilization effects, Reduced sperm viability, Decreased implantation success
| IUD Type | Duration | Mechanism | Efficacy | Menstrual Effect | Insertion Pain |
|---|---|---|---|---|---|
| Copper T380A | 10 years | Copper toxicity | 99.2% | Heavier periods | Moderate-Severe |
| LNG-IUS 52mg | 7 years | Local progestin | 99.8% | Lighter/absent | Moderate |
| LNG-IUS 19.5mg | 5 years | Local progestin | 99.6% | Lighter periods | Moderate |
| LNG-IUS 13.5mg | 3 years | Local progestin | 99.4% | Minimal change | Mild-Moderate |
| Copper T380S | 5 years | Copper toxicity | 99.0% | Heavier periods | Moderate |
⭐ Clinical Pearl: IUD insertion during menstruation reduces pregnancy risk and facilitates cervical dilation, but mid-cycle insertion after negative pregnancy test provides equivalent safety with better visualization
IUD complications include perforation (0.1%), expulsion (2-5%), and pelvic inflammatory disease (0.5%) within first 20 days post-insertion. Perforation risk increases with breastfeeding (6-fold higher), recent delivery (<6 weeks), and inexperienced providers (3-fold increase).
Contraindications include active pelvic infection, undiagnosed vaginal bleeding, uterine anomalies, and copper allergy (copper IUDs). Relative contraindications encompass immunosuppression, severe anemia, and high STI risk requiring individualized assessment.
💡 Master This: IUD success depends on proper patient selection, skilled insertion technique, and appropriate follow-up-master uterine anatomy and insertion protocols, and you provide decade-long contraceptive protection with minimal complications
Post-insertion management requires follow-up at 4-6 weeks for string check and complication assessment. Annual examinations include string visualization, symptom assessment, and STI screening based on risk factors. Removal requires gentle traction on strings with tenaculum stabilization if strings not visible.
Connect intrauterine devices through emergency contraception to understand how post-coital interventions prevent pregnancy through distinct time-sensitive mechanisms.
Mechanism timing determines contraceptive success based on ovulation proximity. Pre-ovulatory administration delays LH surge by 5-7 days, while peri-ovulatory timing may fail to prevent ovulation but disrupts fertilization. Post-ovulatory use shows minimal efficacy as implantation occurs 6-12 days post-conception.
📌 Remember: RAPID for emergency contraception timing - Rapid administration preferred, After 72 hours limited efficacy, Pre-ovulation most effective, Implantation prevention minimal, Delay reduces success rates
| Method | Time Window | Efficacy 0-24h | Efficacy 25-48h | Efficacy 49-72h | Efficacy 73-120h | Mechanism |
|---|---|---|---|---|---|---|
| Levonorgestrel 1.5mg | 72 hours | 89% | 85% | 58% | Not recommended | Ovulation delay |
| Ulipristal 30mg | 120 hours | 95% | 89% | 85% | 85% | Ovulation delay |
| Copper IUD | 120 hours | >99% | >99% | >99% | >99% | Multiple mechanisms |
| Mifepristone 25mg | 120 hours | 98% | 95% | 90% | 85% | Ovulation delay |
| High-dose COCs | 72 hours | 75% | 60% | 45% | Not recommended | Multiple mechanisms |
⭐ Clinical Pearl: BMI >30 reduces levonorgestrel efficacy by 40% and ulipristal efficacy by 20%-consider copper IUD or double-dose levonorgestrel for obese patients requiring emergency contraception
Ulipristal acetate demonstrates superior efficacy compared to levonorgestrel throughout 120-hour window, particularly 48-120 hours post-coital. Selective progesterone receptor modulator action provides more potent ovulation delay and potential anti-implantation effects with minimal side effects.

Contraindications include confirmed pregnancy, severe liver disease, and concurrent enzyme-inducing medications reducing plasma concentrations by 50-75%. Drug interactions with rifampin, phenytoin, and St. John's wort require dose adjustments or alternative methods.
💡 Master This: Emergency contraception success depends on rapid assessment, appropriate method selection, and accurate timing calculations-master the efficacy windows and patient factors, and you prevent thousands of unintended pregnancies through timely intervention
Follow-up protocols include pregnancy testing if menses delayed >7 days, STI screening for high-risk exposures, and ongoing contraceptive counseling. Repeat emergency contraception within same cycle requires careful evaluation and consideration of ongoing contraceptive needs.
Connect emergency contraception through permanent sterilization to understand how surgical contraception provides definitive pregnancy prevention through anatomical modification.
Female sterilization achieves 99.5% efficacy through fallopian tube occlusion, preventing sperm-egg contact in ampullary region where fertilization typically occurs. Laparoscopic techniques include bipolar coagulation, mechanical clips, and silicone bands, each with distinct failure rates and reversal potential.
Tubal ligation methods demonstrate varying efficacy profiles based on technique selection and surgeon experience. Bipolar coagulation achieves lowest failure rates (0.1%) through complete tube destruction, while clip application shows higher failure (0.4%) but better reversal outcomes with 70-80% patency rates post-reversal.
📌 Remember: CLIPS for sterilization methods - Coagulation (bipolar), Ligation (Pomeroy), Implants (Essure), Partial salpingectomy, Silicone bands (Falope rings)
| Sterilization Method | Failure Rate | Reversal Success | Procedure Time | Anesthesia | Recovery |
|---|---|---|---|---|---|
| Laparoscopic Bipolar | 0.1% | 60-70% | 20-30 min | General | 1-2 days |
| Laparoscopic Clips | 0.4% | 70-80% | 15-25 min | General | 1-2 days |
| Laparoscopic Bands | 0.3% | 75-85% | 15-20 min | General | 1-2 days |
| Partial Salpingectomy | 0.05% | 40-50% | 25-35 min | General | 2-3 days |
| Vasectomy | 0.1% | 85-95% | 20-30 min | Local | 2-3 days |
⭐ Clinical Pearl: Post-vasectomy sterility requires 8-16 weeks or 15-20 ejaculations for complete sperm clearance-semen analysis at 8-12 weeks confirms azoospermia before discontinuing backup contraception
Complications include bleeding (1-2%), infection (0.5%), and chronic pain (1-5%) with female procedures showing higher morbidity than vasectomy. Ectopic pregnancy risk increases 7-fold with tubal ligation failure due to partial tube patency allowing sperm passage but restricting embryo transport.

Regret rates vary from 5-20% based on age at sterilization, relationship status, and counseling quality. Factors predicting regret include age <30 years, procedure during cesarean delivery, marital instability, and inadequate pre-procedure counseling.
💡 Master This: Sterilization success requires thorough patient selection, comprehensive counseling, and appropriate technique selection-master the risk-benefit analysis and counseling protocols, and you provide definitive contraception while minimizing regret and complications
Reversal procedures achieve pregnancy rates of 30-80% depending on original technique, remaining tube length, and patient age. Microsurgical anastomosis requires specialized expertise with success rates inversely related to tissue destruction during initial sterilization.
Connect permanent sterilization through comprehensive contraceptive mastery to synthesize optimal method selection strategies for diverse patient populations and clinical scenarios.
Method selection algorithms integrate patient preferences, medical contraindications, lifestyle factors, and reproductive goals into systematic decision frameworks. LARC-first approaches achieve superior real-world efficacy through elimination of user-dependent factors, while individualized counseling addresses cultural, religious, and personal considerations.
📌 Remember: CHOICE for contraceptive counseling - Contraindications assessment, Health history review, Options discussion, Individualized selection, Comprehensive education, Emergency backup planning
| Patient Profile | First-Line Recommendation | Alternative Options | Contraindications | Special Considerations |
|---|---|---|---|---|
| Nulliparous <25 | Hormonal IUD | Implant, COCs | Pregnancy, PID | Insertion technique |
| Multiparous >35 | Copper IUD | Sterilization | Menorrhagia | Long-term efficacy |
| Breastfeeding | Progestin-only | Copper IUD | Estrogen methods | Milk production |
| Cardiovascular Risk | Copper IUD | Barrier methods | Combined hormones | Thrombosis screening |
| Irregular Bleeding | Hormonal IUD | Continuous COCs | Undiagnosed bleeding | Cycle control |
⭐ Clinical Pearl: Migraine with aura represents Category 4 contraindication for combined hormonal methods due to 4-fold stroke risk increase-progestin-only options provide safe alternatives with equivalent efficacy
Cost-effectiveness analysis demonstrates LARC superiority over 5-year timeframes, with IUDs providing $3-7 savings per dollar invested through reduced unintended pregnancy costs. Upfront costs of $500-1000 yield long-term savings compared to annual contraceptive expenses of $200-600.
💡 Master This: Contraceptive mastery combines evidence-based medicine, patient-centered counseling, and systematic risk assessment-understand the selection algorithms and counseling frameworks, and you optimize reproductive health outcomes while minimizing adverse events and patient regret
Quality metrics include method continuation rates, patient satisfaction scores, unintended pregnancy rates, and complication frequencies. Successful programs achieve >80% continuation at 12 months, <5% unintended pregnancy rates, and >90% patient satisfaction through comprehensive counseling and appropriate method matching.
Test your understanding with these related questions
What is the most commonly recommended reversible contraceptive method for a newly married, healthy couple?
Get full access to all lessons, practice questions, and more.
Start Your Free Trial